. Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut. Acta Neuropathol. 2022 Jan;143(1):55-73. Epub 2021 Nov 6 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. UB-312 Synuclein Vaccine Safe in Controls. Next Up: Parkinson's.

Therapeutics

  1. UB-312